161 related articles for article (PubMed ID: 23943543)
1. Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.
Ghosh P; Lee D; Kim KB; Stinchcomb AL
Pharm Res; 2014 Jan; 31(1):148-59. PubMed ID: 23943543
[TBL] [Abstract][Full Text] [Related]
2. Development of a codrug approach for sustained drug delivery across microneedle-treated skin.
Ghosh P; Pinninti RR; Hammell DC; Paudel KS; Stinchcomb AL
J Pharm Sci; 2013 May; 102(5):1458-67. PubMed ID: 23417751
[TBL] [Abstract][Full Text] [Related]
3. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL
J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989
[TBL] [Abstract][Full Text] [Related]
4. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
5. Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.
Ghosh P; Brogden NK; Stinchcomb AL
Mol Pharm; 2013 Jun; 10(6):2331-9. PubMed ID: 23590208
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.
Brogden NK; Banks SL; Crofford LJ; Stinchcomb AL
Pharm Res; 2013 Aug; 30(8):1947-55. PubMed ID: 23761054
[TBL] [Abstract][Full Text] [Related]
7. Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
Banks SL; Pinninti RR; Gill HS; Crooks PA; Prausnitz MR; Stinchcomb AL
Pharm Res; 2008 Jul; 25(7):1677-85. PubMed ID: 18449628
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin.
Banks SL; Paudel KS; Brogden NK; Loftin CD; Stinchcomb AL
Pharm Res; 2011 May; 28(5):1211-9. PubMed ID: 21301935
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin.
Milewski M; Pinninti RR; Stinchcomb AL
J Pharm Sci; 2012 Aug; 101(8):2777-86. PubMed ID: 22628183
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.
Kiptoo PK; Hamad MO; Crooks PA; Stinchcomb AL
J Control Release; 2006 Jun; 113(2):137-45. PubMed ID: 16750868
[TBL] [Abstract][Full Text] [Related]
11. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
Milewski M; Stinchcomb AL
Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.
Yerramreddy TR; Milewski M; Penthala NR; Stinchcomb AL; Crooks PA
Bioorg Med Chem Lett; 2010 Jun; 20(11):3280-3. PubMed ID: 20451376
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application.
Nalluri BN; Anusha SS; Bramhini SR; Amulya J; Sultana AS; Teja CU; Das DB
Curr Drug Deliv; 2015; 12(6):761-9. PubMed ID: 25739035
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin.
Ghosh P; Brogden NK; Stinchcomb AL
J Pharm Sci; 2014 Feb; 103(2):652-60. PubMed ID: 24395718
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.
Eldridge JA; Milewski M; Stinchcomb AL; Crooks PA
Bioorg Med Chem Lett; 2014 Nov; 24(22):5212-5. PubMed ID: 25442314
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium.
Maurya A; Murthy SN
J Pharm Sci; 2014 May; 103(5):1497-503. PubMed ID: 24644068
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents.
Hamad MO; Kiptoo PK; Stinchcomb AL; Crooks PA
Bioorg Med Chem; 2006 Oct; 14(20):7051-61. PubMed ID: 16798000
[TBL] [Abstract][Full Text] [Related]
18. Novel nano-in-micro fabrication technique of diclofenac nanoparticles loaded microneedle patches for localised and systemic drug delivery.
Li M; Vora LK; Peng K; Sabri AHB; Qin N; Abbate M; Paredes AJ; McCarthy HO; Donnelly RF
Biomater Adv; 2024 Jul; 161():213889. PubMed ID: 38781739
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen.
Abioye AO; Issah S; Kola-Mustapha AT
Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660
[TBL] [Abstract][Full Text] [Related]
20. The codrug approach for facilitating drug delivery and bioactivity.
Aljuffali IA; Lin CF; Chen CH; Fang JY
Expert Opin Drug Deliv; 2016 Sep; 13(9):1311-25. PubMed ID: 27159251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]